2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。基本信息 | 登录收藏 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Translational Oncology TRANSL ONCOL (此期刊被最新的JCR期刊SCIE收录) LetPub评分 5.9
60人评分
我要评分
声誉 6.7 影响力 5.0 速度 6.6 | |||||||||||||||||||||
期刊ISSN | 1936-5233 | 微信扫码收藏此期刊 | ||||||||||||||||||||
2023-2024最新影响因子 (数据来源于搜索引擎) | 4.5 点击查看影响因子趋势图 | |||||||||||||||||||||
实时影响因子 | 截止2024年10月29日:3.04 | |||||||||||||||||||||
2023-2024自引率 | 2.20%点击查看自引率趋势图 | |||||||||||||||||||||
五年影响因子 | 4.2 | |||||||||||||||||||||
JCI期刊引文指标 | 1.06 | |||||||||||||||||||||
h-index | 41 | |||||||||||||||||||||
CiteScore ( 2024年最新版) |
| |||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||
期刊官方网站 | https://www.journals.elsevier.com/translational-oncology | |||||||||||||||||||||
期刊投稿网址 | https://www.editorialmanager.com/TRANON | |||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Translational Oncology的语言要求,还能让Translational Oncology编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Translational Oncology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||
是否OA开放访问 | Yes | |||||||||||||||||||||
OA期刊相关信息 | 文章处理费:需要( USD2930; ) 文章处理费豁免:查看说明 其他费用:没有 期刊主题关键词:translational oncology、cancer、genetics、endocrinology、tumour 相关链接:Aims & ScopeAuthor InstructionsEditorial BoardPeer review | |||||||||||||||||||||
通讯方式 | NEOPLASIA PRESS, 1150 W MEDICAL CENTER DR, MSRB III, RM 9303, ANN ARBOR, USA, MI, 48109-0648 | |||||||||||||||||||||
出版商 | Neoplasia Press | |||||||||||||||||||||
涉及的研究方向 | Biochemistry, Genetics and Molecular Biology-Cancer Research | |||||||||||||||||||||
出版国家或地区 | UNITED STATES | |||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||
出版周期 | Quarterly | |||||||||||||||||||||
出版年份 | 2007 | |||||||||||||||||||||
年文章数 | 227点击查看年文章数趋势图 | |||||||||||||||||||||
Gold OA文章占比 | 98.11% | |||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 97.36% | |||||||||||||||||||||
WOS期刊SCI分区 ( 2023-2024年最新版) | WOS分区等级:1区
| |||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2023年12月最新升级版) | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2022年12月升级版) |
| |||||||||||||||||||||
中国科学院SCI期刊分区 ( 2021年12月旧的升级版) |
| |||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1936-5233%5BISSN%5D | |||||||||||||||||||||
平均审稿速度 | 网友分享经验: 较慢,6-12周 | |||||||||||||||||||||
平均录用比例 | 网友分享经验: 较易 | |||||||||||||||||||||
版面费/APC文章处理费信息 | 文章处理费:需要( USD2930; ) 文章处理费豁免:查看说明 其他费用:没有 LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦! | |||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Translational Oncology顺利发表。
快看看作者怎么说吧:服务好评 论文致谢 | |||||||||||||||||||||
期刊常用信息链接 |
|
|
|
中国学者近期发表的论文 | |
1. | Loss of BLK expression as a potential predictor of poor prognosis and immune checkpoint blockade response in NSCLC and contribute to tumor progression Author: Xu, Yingqi; Xu, Jianlin; Qiao, Rong; Zhong, Hua; Xia, Jinjing; Zhong, Runbo Journal: TRANSLATIONAL ONCOLOGY. 2023; Vol. 33, Issue , pp. -. DOI: 10.1016/j.tranon.2023.101671 PubMed DOI |
2. | The roles of Linc-ROR in the regulation of cancer stem cells Author: Wen, Xiaoling; Wu, Yingying; Lou, Yanhui; Xia, Yufang; Yu, Xiao Journal: TRANSLATIONAL ONCOLOGY. 2023; Vol. 28, Issue , pp. -. DOI: 10.1016/j.tranon.2022.101602 PubMed DOI |
3. | Immune microenvironment and therapeutic progress of recurrent hepatocellular carcinoma after liver transplantation Author: Jin, Xin; Ma, Xiaoting; Zhao, Dong; Yang, Lin; Ma, Nan Journal: TRANSLATIONAL ONCOLOGY. 2023; Vol. 28, Issue , pp. -. DOI: 10.1016/j.tranon.2022.101603 PubMed DOI |
4. | circ-ZEB1 regulates epithelial-mesenchymal transition and chemotherapy resistance of colorectal cancer through acting on miR-200c-5p Author: Chen, Hongyu; Zhang, Jianwei; Yang, Lei; Li, Yansen; Wang, Zhenjun; Ye, Chunxiang Journal: TRANSLATIONAL ONCOLOGY. 2023; Vol. 28, Issue , pp. -. DOI: 10.1016/j.tranon.2022.101604 PubMed DOI |
5. | Impact of coronavirus disease 2019 on lung cancer patients: A meta-analysis Author: Wang, Linlin; Wang, Ye; Cheng, Xianbin; Li, Xingzhao; Li, Jun Journal: TRANSLATIONAL ONCOLOGY. 2023; Vol. 28, Issue , pp. -. DOI: 10.1016/j.tranon.2022.101605 PubMed DOI |
6. | Development of novel DNAJB6-KIAA1522-p-mTOR three-protein prognostic prediction models for CRC Author: Jiang, Yu-Juan; Zhang, Tong-Tong; Zhu, Yi-Qing; Cai, Hong-Qing; Chang, Chen; Hao, Jia-Jie; Cai, Yan; Wang, Ming-Rong; Liang, Jian-Wei; Zhang, Yu Journal: TRANSLATIONAL ONCOLOGY. 2023; Vol. 28, Issue , pp. -. DOI: 10.1016/j.tranon.2022.101609 PubMed DOI |
7. | Expression of glucose transporter-1 in follicular lymphoma affected tumor-infiltrating immunocytes and was related to progression of disease within 24 months Author: Deng, Yuwei; Ma, Jianli; Zhao, Shu; Yang, Ming; Sun, Yutian; Zhang, Qingyuan Journal: TRANSLATIONAL ONCOLOGY. 2023; Vol. 28, Issue , pp. -. DOI: 10.1016/j.tranon.2022.101614 PubMed DOI |
8. | Multiregion single cell analysis reveals a novel subtype of cancer-associated fibroblasts located in the hypoxic tumor microenvironment in colorectal cancer Author: Zheng, Nanxin; Wen, Rongbo; Zhou, Leqi; Meng, Qingying; Zheng, Kuo; Li, Zhixuan; Cao, Fuao; Zhang, Wei Journal: TRANSLATIONAL ONCOLOGY. 2023; Vol. 27, Issue , pp. -. DOI: 10.1016/j.tranon.2022.101570 PubMed DOI |
9. | Identification and Validation of Novel Immunogenic Cell Death- and DNA Damage Response-Related Molecular Patterns Correlated with Immune Status and Prognosis in Hepatocellular Carcinoma Author: Zhang, Xiaokai; Wen, Jie; Zhang, Guixiong; Fan, Wenzhe; Tan, Jizhou; Liu, Haikuan; Li, Jiaping Journal: TRANSLATIONAL ONCOLOGY. 2023; Vol. 27, Issue , pp. -. DOI: 10.1016/j.tranon.2022.101600 PubMed DOI |
10. | Effect of transmembrane protein 100 on prostate cancer progression by regulating SCNN1D through the FAK/PI3K/AKT pathway Author: Ye, Zehua; Xia, Yuqi; Li, Lei; Li, BoJun; Chen, Wu; Han, Shangting; Zhou, Xiangjun; Chen, Lijia; Yu, Weimin; Ruan, Yuan; Cheng, Fan Journal: TRANSLATIONAL ONCOLOGY. 2023; Vol. 27, Issue , pp. -. DOI: 10.1016/j.tranon.2022.101578 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2024 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室